Related Experiment Video
Updated: Sep 27, 2025
05:24
Multifractal Spectrum Analysis for Assessing Pulmonary Nodule Malignancy
Published on: January 10, 2025
522
Multimodality management of focal nodular hyperplasia
Damján Pekli1, Bálint Kokas1, Dávid Bárdos1
11 Semmelweis Egyetem, Általános Orvostudományi Kar, Sebészeti, Transzplantációs és Gasztroenterológiai Klinika Budapest, Üllői út 78., 1082 Magyarország.
Orvosi Hetilap
|April 10, 2022
Summary
Focal nodular hyperplasia (FNH), a common benign liver mass, can be managed with observation, transarterial embolization (TAE), or surgical resection. Treatment choice depends on symptom presence and surgical risk.
Area of Science:
- Hepatology
- Interventional Radiology
- Surgical Oncology
Background:
- Focal nodular hyperplasia (FNH) is the second most common benign liver mass, with treatment recommendations varying.
- Current guidelines suggest surgical removal as a relative indication for FNH.
- Diverse treatment modalities exist for managing FNH.
Observation:
- A 40-year-old woman with FNH underwent transarterial embolization (TAE) due to high surgical risk, achieving symptom resolution.
- A 25-year-old woman with symptomatic FNH causing vena cava compression underwent successful liver resection.
Findings:
- Transarterial embolization (TAE) can be effective for FNH, particularly in symptomatic cases or when surgical resection poses a high risk.
- Laparatic resection is a suitable primary treatment for lower-risk FNH patients.
- Long-term follow-up may suffice for asymptomatic FNH.
Implications:
- This study highlights tailored treatment strategies for FNH based on individual patient factors.
- It emphasizes the efficacy of TAE as an alternative or adjunct to surgery for FNH.
- The findings support personalized management approaches for benign liver tumors.
Related Concept Videos
01:26Nephrotic Syndrome II : Assessment and Medical Management
32
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
32
01:22Myocarditis IV: Nursing Management
48
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
48
01:19Mitral Valve Prolapse III: Nursing Management
43
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
43
01:25Mitral Regurgitation III: Medical Management
39
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
39